|
||||||||||||||||||||||||||||||||||||
1Centers for Disease Control and Prevention. HIV Surveillance Report, 2011;
vol. 23. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Published February 2013. Accessed August 27, 2014. 2United States Census 2010. 2010 Census Interactive Population Search. http://www.census.gov/2010census/popmap/ipmtext.php?fl=28. Accessed August 27, 2014. 3Persons living with diagnosed HIV infection, year-end 2010. Rates are per 100,000 population. 4ClinicalTrials.gov. http://clinicaltrials.gov/ct2/help/how-use-search-results. Accessed August 27, 2014. |
||||||||||||||||||||||||||||||||||||
Table 1: Demographic and social characteristics1, 2 of the 3 U.S. cities from which persons were enrolled for African Americans’ willingness to participate in HIV vaccine trials study. |